Cell cycle dependent response and combined treatment of tumor
- PMID: 77340
Cell cycle dependent response and combined treatment of tumor
Abstract
Attempt was made to summarize data indicating cell cycle dependence of survival response to various antitumor agents. Normalized patterns of survival response permitted us to group agents into two major categories. It was known that effect of agents on cell progression was not only related to respective periods of the cell cycle but also rather specific for each category of agents. The extent of progression inhibition was not compared on a quantitative basis. On the basis of above findings a rational combination and a scheduled administration of agents for effective sterilization of tumor cells were considered.
Similar articles
-
Four-drug combination chemotherapy in extensive non-small cell lung cancer: a Southwest Oncology Group Pilot Study.Cancer Treat Rep. 1981 Jan-Feb;65(1-2):143-4. Cancer Treat Rep. 1981. PMID: 6164484 No abstract available.
-
Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum).Anticancer Res. 1983 Jul-Aug;3(4):235-8. Anticancer Res. 1983. PMID: 6192751 Clinical Trial.
-
[The effects of etretinate and anticancer drugs on the cell line of a squamous cell carcinoma of human skin (HSC-1)].Nihon Hifuka Gakkai Zasshi. 1989 May;99(6):673-82. Nihon Hifuka Gakkai Zasshi. 1989. PMID: 2479784 Japanese.
-
The role of cell kinetics in cancer chemotherapy.Semin Oncol. 1977 Jun;4(2):217-26. Semin Oncol. 1977. PMID: 327554 Review. No abstract available.
-
Clinical aspects of drug resistance.Antibiot Chemother (1971). 1978;23:238-46. doi: 10.1159/000401487. Antibiot Chemother (1971). 1978. PMID: 348082 Review. No abstract available.